Reduced myocardial sarcoplasmic reticulum Ca(2+)-ATPase protein expression in compensated primary and secondary human

U Schotten1, B Koenigs, M Rueppel

  • 1Department of Cardiology, Medical Faculty, University of Technology, Pauwelsstrasse 30, Aachen, D-52057, Germany. usch@pcserver.mk1.rwth-qqchen.de

Insights

In hypertrophied human hearts, the expression of SR Ca(2+)-ATPase, a key calcium transporter, is reduced. This decrease may impair calcium handling and contribute to altered heart muscle contraction.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Altered intracellular calcium handling is implicated in the contractile dysfunction of hypertrophied myocardium.
  • The expression of calcium transport proteins in compensated human left ventricular hypertrophy remains largely uncharacterized.

Purpose of the Study:

  • To investigate the myocardial protein expression of key intracellular calcium transport proteins in compensated human left ventricular hypertrophy.
  • To determine if alterations in sarcoplasmic reticulum calcium ATPase (SR Ca(2+)-ATPase) expression correlate with the degree of hypertrophy.

Main Methods:

  • Septal myocardial specimens from patients with hypertrophic obstructive cardiomyopathy (n=14) and aortic valve stenosis (n=11) were analyzed.
  • Non-hypertrophied myocardium from six non-failing hearts served as controls.
  • Sarcoplasmic reticulum (SR) calcium release channel density was measured by (3)H-ryanodine binding; SR Ca(2+)-ATPase, phospholamban, calsequestrin, and Na(+)/Ca(2+)-exchanger levels were quantified by Western blot.

Main Results:

  • SR calcium release channel density was not significantly different between hypertrophied and non-failing myocardium.
  • SR Ca(2+)-ATPase expression was reduced by approximately 30% in both hypertrophic conditions compared to controls (P<0.05).
  • Expression of phospholamban, calsequestrin, and Na(+)/Ca(2+)-exchanger remained unchanged; SR Ca(2+)-ATPase reduction was inversely correlated with septum thickness.

Conclusions:

  • Human left ventricular hypertrophy, both primary and secondary, is associated with reduced SR Ca(2+)-ATPase expression.
  • This diminished SR Ca(2+)-ATPase expression may lead to impaired SR calcium reuptake, potentially contributing to altered contractile function in hypertrophied hearts.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...